Hypha Labs, Inc.
Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Hypha Labs, Inc. (FUNI) - Total Assets
Latest total assets as of December 2025: $391.60K USD
Based on the latest financial reports, Hypha Labs, Inc. (FUNI) holds total assets worth $391.60K USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hypha Labs, Inc. - Total Assets Trend (2011–2025)
This chart illustrates how Hypha Labs, Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hypha Labs, Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Hypha Labs, Inc.'s total assets of $391.60K consist of 78.3% current assets and 21.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Hypha Labs, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hypha Labs, Inc.'s current assets represent 78.3% of total assets in 2025, an increase from 76.2% in 2011.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2025, down from 64.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Hypha Labs, Inc. Competitors by Total Assets
Key competitors of Hypha Labs, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Hypha Labs, Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hypha Labs, Inc. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Hypha Labs, Inc. is currently not profitable relative to its asset base.
Hypha Labs, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.24 | 0.12 | 0.32 |
| Quick Ratio | 0.24 | 0.12 | 0.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.01 Million | $ -1.29 Million | $ -572.90K |
Hypha Labs, Inc. - Advanced Valuation Insights
This section examines the relationship between Hypha Labs, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.43 |
| Latest Market Cap to Assets Ratio | 9.16 |
| Asset Growth Rate (YoY) | -17.1% |
| Total Assets | $409.22K |
| Market Capitalization | $3.75 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Hypha Labs, Inc.'s assets at a significant premium ( 9.16x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Hypha Labs, Inc.'s assets decreased by 17.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Hypha Labs, Inc. (2011–2025)
The table below shows the annual total assets of Hypha Labs, Inc. from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $409.22K | -17.13% |
| 2024-09-30 | $493.81K | -64.97% |
| 2023-09-30 | $1.41 Million | +5.19% |
| 2022-09-30 | $1.34 Million | -29.03% |
| 2021-09-30 | $1.89 Million | +5.57% |
| 2020-09-30 | $1.79 Million | +31.89% |
| 2019-09-30 | $1.36 Million | -3.09% |
| 2018-09-30 | $1.40 Million | -10.95% |
| 2017-09-30 | $1.57 Million | +8.60% |
| 2016-09-30 | $1.45 Million | -33.41% |
| 2015-09-30 | $2.17 Million | -61.73% |
| 2014-09-30 | $5.68 Million | +2123.66% |
| 2013-09-30 | $255.34K | -27.31% |
| 2012-09-30 | $351.25K | +32.68% |
| 2011-09-30 | $264.74K | -- |